Hepatitis: New doubts about preventing HAV superinfection in chronic HCV.
Daniel
D
Shouval
D003362:Cost-Benefit Analysis; D006506:Hepatitis A / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000191:economics / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D017410:Practice Guidelines as Topic; D015995:Prevalence; D012307:Risk Factors; D015163:Superinfection / Q000453:epidemiology / Q000517:prevention & control*; D015996:Survival Rate
D022362:Hepatitis A Vaccines